Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian A Simon

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Cell|May 23, 2006
Using isoform-specific inhibitors to target lipid kinasesJulian A Simon
Developmental Cell|August 16, 2003
Sir2 flexes its muscleAntonio Bedalov, Julian A Simon
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 9, 2005
[Chemistry and biology of NAD-dependent deacetylases]Julian A Simon, Maki Hirao
Molecular Cancer Therapeutics|March 19, 2008
A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activitiesShlomo Handeli, Julian A Simon
Nature Reviews. Cancer|June 2, 2004
Yeast as a model system for anticancer drug discoveryJulian A Simon, Antonio Bedalov
Science (New York, N.Y.)|August 18, 2004
Neuroscience. NAD to the rescueAntonio Bedalov, Julian A Simon
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2003
Novel approaches to screen for anticancer drugs using Saccharomyces cerevisiaeJulian A Simon, Timothy J Yen
Molecular & Cellular Proteomics : MCP|October 31, 2009
A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting proteinJacob J Gano, Julian A Simon
Journal of the Association for Research in Otolaryngology : JARO|July 7, 2011
Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral lineYoshinobu Hirose, Julian A Simon, Henry C Ou
Handbook of Experimental Pharmacology|September 1, 2011
Sirtuin modulatorsSumit S Mahajan, Vid Leko, Julian A Simon, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cell|May 23, 2006
Using isoform-specific inhibitors to target lipid kinasesJulian A Simon
Developmental Cell|August 16, 2003
Sir2 flexes its muscleAntonio Bedalov, Julian A Simon
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 9, 2005
[Chemistry and biology of NAD-dependent deacetylases]Julian A Simon, Maki Hirao
Molecular Cancer Therapeutics|March 19, 2008
A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activitiesShlomo Handeli, Julian A Simon
Nature Reviews. Cancer|June 2, 2004
Yeast as a model system for anticancer drug discoveryJulian A Simon, Antonio Bedalov
Science (New York, N.Y.)|August 18, 2004
Neuroscience. NAD to the rescueAntonio Bedalov, Julian A Simon
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2003
Novel approaches to screen for anticancer drugs using Saccharomyces cerevisiaeJulian A Simon, Timothy J Yen
Molecular & Cellular Proteomics : MCP|October 31, 2009
A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting proteinJacob J Gano, Julian A Simon
Journal of the Association for Research in Otolaryngology : JARO|July 7, 2011
Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral lineYoshinobu Hirose, Julian A Simon, Henry C Ou
Handbook of Experimental Pharmacology|September 1, 2011
Sirtuin modulatorsSumit S Mahajan, Vid Leko, Julian A Simon, et al.
Pageof 6